Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials
Endocrinology and Metabolism · 30.04.2026 · 41 (2) · 203-209
DOI: 10.3803/enm.2026.2938 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism, erschienen am 30.04.2026. Verfasst von Sung Hye Kong. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. shkong@s…. Hauptthemen laut MEDLINE: Vitamin D, Fractures, Bone, Vitamin D Deficiency. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Endocrine Society.
Abstract (Originalsprache)
For decades, vitamin D has been a cornerstone of preventive medicine. However, recent large-scale randomized controlled trials have failed to replicate the broad benefits previously observed in epidemiological studies, particularly with respect to fracture and fall prevention in vitamin D-replete populations. Moreover, growing evidence suggesting an increased fall risk associated with high-dose bolus administration has necessitated a re-evaluation of safety assumptions. This review synthesizes these discordant findings to propose a framework grounded in precision medicine. We explore the ‘divergent threshold’ hypothesis, whereby a serum 25-hydroxyvitamin D level of 20 to 30 ng/mL may be sufficient for skeletal health, whereas a higher threshold of 40 to 50 ng/mL appears necessary to achieve metabolic benefits, such as diabetes prevention in non-obese individuals. Ultimately, we advocate a shift away from a ‘one-size-fits-all’ paradigm toward targeted strategies that maximize efficacy while minimizing the risks associated with excess supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. shkong@snu.ac.kr.
Förderung
- Korean Endocrine Society
Zitieren
APA
Kong, S. H. (2026). Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials. Endocrinology and Metabolism, 41(2), 203-209. https://doi.org/10.3803/enm.2026.2938
Vancouver
Kong SH. Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials. Endocrinology and Metabolism. 2026;41(2):203-209. doi:10.3803/enm.2026.2938
BibTeX
@article{Kong2026,
author = {Kong, Sung Hye},
title = {Revisiting the Role of Vitamin D in Fracture Prevention in the Era of Mega-Trials},
journal = {Endocrinology and Metabolism},
year = {2026},
volume = {41},
number = {2},
pages = {203--209},
doi = {10.3803/enm.2026.2938}
}
EUVIMED